# Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis

> **NCT04433481** · NA · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 84 (estimated)

## Conditions studied

- Liver Cirrhosis
- Portal Vein Thrombosis

## Interventions

- **DRUG:** Dabigatran
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04433481
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-20
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04433481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04433481, "Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04433481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*